JP2019527228A5 - - Google Patents

Download PDF

Info

Publication number
JP2019527228A5
JP2019527228A5 JP2019503748A JP2019503748A JP2019527228A5 JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5 JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl group
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019527228A (ja
JP6985367B2 (ja
Filing date
Publication date
Priority claimed from GBGB1613054.4A external-priority patent/GB201613054D0/en
Application filed filed Critical
Publication of JP2019527228A publication Critical patent/JP2019527228A/ja
Publication of JP2019527228A5 publication Critical patent/JP2019527228A5/ja
Application granted granted Critical
Publication of JP6985367B2 publication Critical patent/JP6985367B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503748A 2016-07-28 2017-07-27 新規化合物および方法 Active JP6985367B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1613054.4 2016-07-28
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (3)

Publication Number Publication Date
JP2019527228A JP2019527228A (ja) 2019-09-26
JP2019527228A5 true JP2019527228A5 (OSRAM) 2021-06-17
JP6985367B2 JP6985367B2 (ja) 2021-12-22

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019503748A Active JP6985367B2 (ja) 2016-07-28 2017-07-27 新規化合物および方法

Country Status (19)

Country Link
US (1) US10710998B2 (OSRAM)
EP (1) EP3490988B1 (OSRAM)
JP (1) JP6985367B2 (OSRAM)
KR (1) KR102396059B1 (OSRAM)
CN (1) CN109641891B (OSRAM)
CY (1) CY1122138T1 (OSRAM)
DK (1) DK3490988T3 (OSRAM)
ES (1) ES2751948T3 (OSRAM)
GB (1) GB201613054D0 (OSRAM)
HR (1) HRP20192109T1 (OSRAM)
HU (1) HUE046509T2 (OSRAM)
LT (1) LT3490988T (OSRAM)
PL (1) PL3490988T3 (OSRAM)
PT (1) PT3490988T (OSRAM)
RS (1) RS59566B1 (OSRAM)
SI (1) SI3490988T1 (OSRAM)
SM (1) SMT201900582T1 (OSRAM)
TW (1) TWI739871B (OSRAM)
WO (1) WO2018020249A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3231444T3 (pl) 2014-05-12 2020-05-18 Verona Pharma Plc Nowe leczenie
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
AU2021207775B2 (en) * 2020-01-17 2025-12-11 Lupin Limited Methods, processes and intermediates for preparing chroman compounds
KR20240004495A (ko) 2021-04-29 2024-01-11 쑤저우 선카디아 바이오파마수티컬즈 컴퍼니 리미티드 이소퀴놀론 화합물과 이의 용도
KR20240119082A (ko) * 2021-12-14 2024-08-06 시젱 하이스코 파마수티칼 씨오., 엘티디. 트리사이클릭 융합된 헤테로사이클릭 pde3/4 이중 억제제 및 이의 용도
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
US12194045B1 (en) 2023-06-26 2025-01-14 Verona Pharma Plc Particulate composition
US20250073240A1 (en) 2023-09-06 2025-03-06 Verona Pharma Plc New treatment
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
US20250249007A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
WO2000058308A1 (en) 1999-03-31 2000-10-05 Vernalis Limited DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE
DK2603509T3 (da) 2010-08-09 2014-09-08 Verona Pharma Plc KRYSTALLINSK FORM AF PYRIMIDIO [6,1- a] ISOQUINOLIN-4-ON-FORBINDELSE
PT2968312T (pt) 2013-03-15 2018-04-19 Verona Pharma Plc Combinação de fármacos
PL3231444T3 (pl) 2014-05-12 2020-05-18 Verona Pharma Plc Nowe leczenie
HUE055527T2 (hu) 2014-09-15 2021-12-28 Verona Pharma Plc RPL554-t tartalmazó folyékony inhalációs készítmény
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Similar Documents

Publication Publication Date Title
JP2019527228A5 (OSRAM)
JP7440989B2 (ja) 2-[5-(3-クロロフェニル)-3-ヒドロキシピリジン-2-カルボニル]アミノ]酢酸を調製するための方法
JP6633539B2 (ja) 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換−ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
TWI768716B (zh) 二芳基硫尿囊素化合物、其中間體及其製備方法
JP2018522724A (ja) シュウ酸アミド系配位子および銅触媒によるハロゲン化アリールのカップリング反応におけるその使用
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
HRP20192109T1 (hr) Novi spoj i proces
JP6954456B2 (ja) スルファミン酸リチウムの製造方法及び新規スルファミン酸リチウム
RU2012134783A (ru) Способ получения солей тетразолметансульфоновой кислоты и новое соединение, используемое в нем
CA3070070A1 (en) Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
TW201713616A (zh) 製造雙胍鹽及s-三之方法
TW202024059A (zh) 吡啶並〔2,3-d〕嘧啶-7(8h)-酮的合成
JP2014511387A5 (OSRAM)
KR20230135109A (ko) 3-(2-클로로티아졸-5-일)-8-메틸-7-옥소-6-페닐-2,3-디히드로티아졸로[3,2-a]피리미딘-4-이움-5-올레이트의거울상이성질체 풍부 형태의 제조 방법
JP2021504505A5 (OSRAM)
JP2019521165A5 (OSRAM)
JP2013527149A5 (OSRAM)
JP2012509267A5 (ja) (R)−3−(2,3−ジヒドロキシプロピル)−6−フルオロ−5−(2−フルオロ−4−ヨードフェニルアミノ)−8−メチルピリド[2,3−d]ピリミジン−4,7(3H,8H)−ジオンを製造するためのプロセス及びその中間体
JP2024056922A (ja) ジアミノピリミジン誘導体またはその酸付加塩の新規な製造方法
JP2022153486A (ja) 殺有害生物化合物の調製方法
JP2010024173A (ja) 9−アミノシンコナアルカロイドの製造法
CN106854125B (zh) 一种制备含有两个手性中心α-氟-β-乙炔基酮化合物的方法
JP7349551B2 (ja) 含フッ素ピリミジン化合物およびその製造方法
JP4066630B2 (ja) 2−置換チオピリミジン−4−カルボン酸エステルの製法
JP7097363B2 (ja) 殺有害生物化合物の調製方法